Flotek Industries Stock (NYSE:FTK), Trade Ideas

Flotek Industries

Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

FREE

HLGN

The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

$1.5M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

CXDO

OCGN

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

ASPI

TYDE

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Top 4 Materials Stocks That Set To Fly In April

Flotek Industries Inc

Fujita Kanko Inc

WIIM

Flotek Industries shares are trading higher. The company reported Q4 financial results.

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:04 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Flotek Industries missed estimated earnings by -22.0%, reporting an EPS of $0.07 versus an estimate of $0.09.
Revenue was down $6.03 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.03 which was followed by a 11.0% drop in the share price the next day.

To track all earnings releases for Flotek Industries <a href="https://www.benzinga.com/quote/FTK/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Recap: Flotek Industries Q4 Earnings

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. The company reported quarterly sales of $42.188 million which missed the analyst consensus estimate of $47.250 million by 10.71 percent. This is a 12.50 percent decrease over sales of $48.217 million the same period last year.

Earnings Misses

Flotek Industries Q4 2023 GAAP EPS $0.07 Misses $0.08 Estimate, Sales $42.188M Miss $47.250M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) is likely to report earnings for its fourth quarter.
&bull; MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $530.30 million.
&bull; BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) is likely to report quarterly loss at $0.91 per share on revenue of $710 thousand.
&bull; Enfusion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $45.27 million.
&bull; Tupperware Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) is estimated to report earnings for its second quarter.
&bull; Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $214.08 million.
&bull; Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) is projected to report quarterly loss at $0.22 per share on revenue of $222.43 million.
&bull; FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $34.53 million.
&bull; Archer-Daniels Midland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) is projected to report quarterly earnings at $1.43 per share on revenue of $23.64 billion.
&bull; On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $510.19 million.
&bull; Chicago Atlantic Real (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFI#NASDAQ">REFI</a>) is projected to report quarterly earnings at $0.51 per share on revenue of $16.09 million.
&bull; Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $-250 thousand.
&bull; Kohl&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is estimated to report quarterly earnings at $1.28 per share on revenue of $5.70 billion.
&bull; PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWFL#NASDAQ">PWFL</a>) is likely to report quarterly loss at $0.10 per share on revenue of $34.34 million.
&bull; Lifetime Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCUT#NASDAQ">LCUT</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $197.93 million.
&bull; IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $476.18 million.
&bull; Bioventus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $123.96 million.
&bull; Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) is projected to report quarterly loss at $0.09 per share on revenue of $3.24 million.
&bull; Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) is expected to report quarterly loss at $0.10 per share on revenue of $201.84 million.
&bull; Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) is estimated to report earnings for its fourth quarter.
&bull; Hagerty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGTY#NYSE">HGTY</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $245.27 million.
&bull; ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) is projected to report earnings for its fourth quarter.
&bull; Core Molding Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMT#AMEX">CMT</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $70.75 million.
&bull; Intl Game Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) is projected to report quarterly earnings at $0.41 per share on revenue of $1.11 billion.
&bull; Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) is projected to report quarterly loss at $0.13 per share on revenue of $48.40 million.
<h3>Companies Reporting After The Bell</h3>
&bull; ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) is projected to report quarterly loss at $0.20 per share on revenue of $6.53 million.
&bull; Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $172.68 million.
&bull; MaxCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) is likely to report quarterly loss at $0.07 per share on revenue of $13.09 million.
&bull; Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $111.13 million.
&bull; Performant Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFMT#NASDAQ">PFMT</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $31.59 million.
&bull; Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $592.58 million.
&bull; Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) is likely to report quarterly loss at $0.08 per share on revenue of $27.00 million.
&bull; Rackspace Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) is projected to report quarterly loss at $0.04 per share on revenue of $714.72 million.
&bull; Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $45.74 million.
&bull; Intl General Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) is likely to report earnings for its fourth quarter.
&bull; Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is projected to report quarterly loss at $0.15 per share on revenue of $13.48 million.
&bull; Aligos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) is projected to report quarterly loss at $0.27 per share on revenue of $1.60 million.
&bull; Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $33.52 million.
&bull; Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) is likely to report earnings for its fourth quarter.
&bull; SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) is likely to report earnings for its fourth quarter.
&bull; Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) is projected to report quarterly loss at $2.00 per share on revenue of $2.10 million.
&bull; Doma Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOMA#NYSE">DOMA</a>) is likely to report quarterly loss at $1.30 per share on revenue of $69.42 million.
&bull; Beauty Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) is projected to report quarterly loss at $0.07 per share on revenue of $87.63 million.
&bull; Laird Superfood (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LSF#AMEX">LSF</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $8.74 million.
&bull; Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is projected to report quarterly loss at $0.13 per share on revenue of $29.34 million.
&bull; Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $4.43 million.
&bull; Heron Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) is expected to report quarterly loss at $0.16 per share on revenue of $30.97 million.
&bull; AdTheorent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTH#NASDAQ">ADTH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $56.20 million.
&bull; Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) is likely to report quarterly loss at $0.03 per share on revenue of $30.00 million.
&bull; Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $262.30 million.
&bull; icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.30 million.
&bull; Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) is expected to report quarterly loss at $0.18 per share on revenue of $145.56 million.
&bull; Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) is projected to report quarterly loss at $0.03 per share on revenue of $73.07 million.
&bull; Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) is likely to report quarterly loss at $1.38 per share on revenue of $1.06 million.
&bull; Transact Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TACT#NASDAQ">TACT</a>) is projected to report quarterly loss at $0.03 per share on revenue of $13.60 million.
&bull; loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $236.76 million.
&bull; CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) is estimated to report quarterly loss at $0.29 per share on revenue of $58.40 million.
&bull; Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) is likely to report quarterly loss at $0.10 per share on revenue of $42.84 million.
&bull; Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $480.25 million.
&bull; Westrock Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $226.02 million.
&bull; Eastern Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EML#NASDAQ">EML</a>) is likely to report earnings for its fourth quarter.
&bull; BRT Apartments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRT#NYSE">BRT</a>) is estimated to report earnings for its fourth quarter.
&bull; Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) is expected to report quarterly loss at $0.06 per share on revenue of $87.21 million.
&bull; Aware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWRE#NASDAQ">AWRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) is likely to report quarterly loss at $0.11 per share on revenue of $151.50 million.
&bull; Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) is projected to report quarterly loss at $0.23 per share on revenue of $69.06 million.
&bull; Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $47.25 million.
&bull; PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $9.37 million.
&bull; Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) is likely to report quarterly loss at $0.15 per share on revenue of $33.79 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADTH

ALGS

ATER

AWRE

BIRD

BLDE

BTAI

BTMD

CLOV

CLPT

CLSD

CRMD

CSBR

CYRX

DOMA

ENFN

GHLD

HGTY

HRTX

ICAD

IGIC

INVE

LCUT

MANU

MHLD

MNSO

MXCT

NATR

NOTE

NRGV

ONON

OPRT

PFMT

PHUN

PRPL

PRTH

PWFL

QFIN

QRHC

REFI

RERE

SIGA

SKIN

SNCR

SURG

SWIM

TACT

TNON

VERI

WEST

WKHS

Earnings Scheduled For March 12, 2024

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-12. Here's what investors need to know before the announcement.
Analysts estimate that Flotek Industries will report an earnings per share (EPS) of $0.09. 
Flotek Industries bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.03, which was followed by a 11.27% drop in the share price the next day.
Here's a look at Flotek Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.01</td>
<td>-0.12</td>
<td>-0.48</td>
<td>-0.42</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.04</td>
<td>-0.12</td>
<td>-0.12</td>
<td>-1.50</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-11.0%</td>
<td>-4.0%</td>
<td>5.0%</td>
<td>-14.000000000000002%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1710172875_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Flotek Industries were trading at $2.79 as of March 08. Over the last 52-week period, shares are down 53.47%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/FTK/earnings">To track all earnings releases for Flotek Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Flotek Industries's Earnings

Stock Split

Flotek Board Approves 1-for-6 Reverse Stock Split, Effective After Market Close Sept. 25

Guidance

Flotek Expects To Report Positive Adj. EBITDA For Q3

Flotek Announces Entry into Asset Based Loan Agreement Of Up To $10M

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 60 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $50.59 million which beat the analyst consensus estimate of $47.80 million by 5.85 percent. This is a 72.25 percent increase over sales of $29.37 million the same period last year.

Earnings Beats

Flotek Industries Q2 EPS $(0.02), Inline, Sales $50.59M Beat $47.80M Estimate

The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Whole Earth Brands </h3>
<ul>
<li>The Trade: Whole Earth Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/free#NASDAQ">FREE</a>) 10% owner Sababa Holdings Free LLC <a href="https://www.benzinga.com/quote/FREE/analyst-ratings"> acquired a total 488,923 shares </a> an average price of $3.00. To acquire these shares, it cost around $1.47 million.</li>
<li>What&rsquo;s Happening: Whole Earth Brands posted a loss for the first quarter.</li>
<li>What Whole Earth Brands Does: Whole Earth Brands Inc is a food company enabling healthier lifestyles and providing access to high-quality, plant-based sweeteners, flavor enhancers and other foods through diverse portfolio of trusted brands and delicious products.</li>
</ul>
<h3>Flotek Industries </h3>
<ul>
<li>The Trade: Flotek Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftk#NYSE">FTK</a>) Director Matt Wilks <a href="https://www.benzinga.com/quote/CURO/analyst-ratings"> acquired a total of 54,539 shares </a> at an average price of $0.78. The insider spent around $42.54 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Flotek promoted President Ryan Ezell to CEO.</li>
<li>What Flotek Industries Does: Flotek Industries Inc delivers chemistry-based technology solutions for energy, industrial, and consumer applications.</li>
</ul>
<h3>Rubicon Technologies</h3>
<ul>
<li>The Trade: Rubicon Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbt#NYSE">RBT</a>) 10% owner Jose Miguel Enrich <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 240,154 shares </a> at an average price of $0.42. To acquire these shares, it cost around $100 thousand.</li>
<li>What&rsquo;s Happening: Rubicon Technologies issued an update on enhanced liquidity and progress of strategic plan.</li>
<li>What Rubicon Technologies Does: Rubicon Technologies Inc is a software platform providing full-service waste management, recycling, and smart city technology solutions.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/23/06/32945293/top-5-financial-stocks-that-could-sink-your-portfolio-in-q2"> Top 5 Financial Stocks That Could Sink Your Portfolio In Q2 </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Heliogen </h3>
<ul>
<li>The Trade: Heliogen, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlgn#NYSE">HLGN</a>) 10% owner Patrick Soonshiong <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 366,659 shares </a> at an average price of $0.23. The insider spent $85.39 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Heliogen and NantG Power reported a strategic collaboration to innovate solar thermal calcination design.</li>
<li>What Heliogen Does: Heliogen Inc is a concentrated solar energy system that is being developed to unlock the power of sunlight to replace fossil fuels.</li>
</ul>

The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Ocugen </h3>
<ul>
<li>The Trade: Ocugen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocgn#NASDAQ">OCGN</a>) Director Junge Zhang <a href="https://www.benzinga.com/quote/NRDY/analyst-ratings"> acquired a total 200,278 shares </a> an average price of $0.50. To acquire these shares, it cost around $100 thousand.</li>
<li>What&rsquo;s Happening: Ocugen announced the pricing of its $16.5 million public offering of 30 million shares of common stock.</li>
<li>What Ocugen Does: Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19.</li>
</ul>
<h3>Flotek Industries </h3>
<ul>
<li>The Trade: Flotek Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftk#NYSE">FTK</a>) Director Matthew Wilks <a href="https://www.benzinga.com/quote/CURO/analyst-ratings"> acquired a total of 172,447 shares </a> at an average price of $0.79. The insider spent around $136.23 thousand to buy those shares.</li>
<li>What&rsquo;s Happening: Flotek promoted President Ryan Ezell to CEO.</li>
<li>What Flotek Industries Does: Flotek Industries Inc delivers chemistry-based technology solutions for energy, industrial, and consumer applications.</li>
</ul>
<h3>Crexendo</h3>
<ul>
<li>The Trade: Crexendo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxdo#NASDAQ">CXDO</a>) Director Steven G Mihaylo <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 43,700 shares </a> at an average price of $1.87. To acquire these shares, it cost around $81.86 thousand.</li>
<li>What&rsquo;s Happening: Crexendo posted upbeat quarterly results.</li>
<li>What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/06/32891767/top-5-consumer-stocks-that-may-explode-in-june"> Top 5 Consumer Stocks That May Explode In June </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Management

Flotek Promotes President Ryan Ezell to CEO

&nbsp;Flotek Industries, Inc. (&quot;Flotek&quot; or the &quot;Company&quot;) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) today announced it has received written notice from the New York Stock Exchange (the &quot;NYSE&quot;) that the average closing price of the Company&#39;s shares of common stock was below&nbsp;$1.00&nbsp;per share over a period of 30 consecutive trading days, which is below the requirement for continued listing on the NYSE.
In accordance with applicable NYSE procedures, the Company plans to notify the NYSE that it intends to cure the&nbsp;$1.00&nbsp;per share&nbsp;deficiency. Based on the applicable NYSE procedures, the Company has six months following the receipt of the notice to cure the deficiency and regain compliance. The notice has no immediate impact on the listing of the Company&#39;s common stock, which will continue to trade on the NYSE subject to the Company&#39;s continued compliance with the other listing requirements of the NYSE. The common stock of the Company will continue to trade under the symbol &quot;FTK,&quot; but will have an added designation of &quot;.BC&quot; to indicate that the status of the common stock is &quot;below compliance&quot; with the NYSE continued listing standards. The&nbsp;&quot;.BC&quot; indicator will be removed at such time as the Company is deemed to be in compliance. The Company intends to monitor the closing share price for its common stock and explore available options to regain compliance, which may include, if necessary, effectuating a reverse stock split.
The Company&#39;s stockholders approved a proposal at the Company&#39;s 2022 annual meeting giving the Board of Directors of the Company (the &quot;Board&quot;) authority to effect a reverse stock split of the Company&#39;s common stock at a ratio to be determined by the Board ranging from a ratio of one to three to a ratio of one to six. If the Board determines to implement the reverse stock split, the Company will issue a press release announcing the terms and effective date before it takes effect.

Flotek Receives Continued Listing Standard Notice From NYSE

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30.</a>
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>ASP Isotopes Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aspi#NASDAQ">ASPI</a>)</h3>
<ul>
<li>ASP Isotopes announced a $5 million private placement priced at-the-market under Nasdaq rules. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/ASPI">52-week low of $0.73 </a>.</li>
<li>RSI Value: 29.67</li>
<li>ASPI Price Action: Shares of ASP Isotopes fell 4.1% to close at $0.8538 on Friday.</li>
</ul>
<h3>IT Tech Packaging, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/itp#NYSE">ITP</a>)</h3>
<ul>
<li>IT Tech Packaging posted a Q4 loss of $1.19 per share. Mr. Zhenyong Liu, Chairman and Chief Executive Officer of the Company, commented, &quot;In fiscal year 2022, our business execution was reflected as we generated approximately $100.35 million in revenue and approximately $4.75 million in gross profit.&quot; The company&rsquo;s <a href="https://www.benzinga.com/quote/ITP"> stock has a 52-week low </a> of $0.36.</li>
<li>RSI Value: 28.24</li>
<li>ITP Price Action: Shares of IT Tech Packaging gained 1.2% to close at $0.3751 on Friday.</li>
</ul>
<h3>Flotek Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftk#NYSE">FTK</a>)</h3>
<ul>
<li>Flotek Industries posted a Q4 loss of $0.25 per share. Harsha V. Agadi, Interim Chief Executive Officer of Flotek stated, &quot;In the fourth quarter, we achieved another quarter of increased volumes, strong revenue growth, and improving operational performance while managing our liquidity to facilitate continued growth.&quot; The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/FTK"> low of $0.66.</a></li>
<li>RSI Value: 22.56</li>
<li>FTK Price Action: Shares of Flotek Industries fell 3.4% to close at $0.69 on Friday.</li>
</ul>
<h3>Cryptyde, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyde#NASDAQ">TYDE</a>)</h3>
<ul>
<li>Cryptyde issued a <a href="https://www.benzinga.com/quote/TYDE"> corporate update </a> on its subsidiary, Forever 8 Fund, LLC. The company&rsquo;s 52-week low is $0.0780.</li>
<li>RSI Value: 22.67</li>
<li>TYDE Price Action: Shares of Cryptyde fell 1.4% to close at $0.0832 on Friday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/03/31608540/over-40m-bet-on-89bio-check-out-these-3-stocks-insiders-are-buying"> Over $40M Bet On 89bio? Check Out These 3 Stocks Insiders Are Buying </a>

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.07) by 257.14 percent. This is a 127.27 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $48.22 million which missed the analyst consensus estimate of $51.30 million by 6.01 percent. This is a 296.72 percent increase over sales of $12.15 million the same period last year.

Flotek Industries Q4 EPS $(0.25) May Not Compare To $(0.07) Estimate, Sales $48.22M Miss $51.30M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Niu Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is likely to report earnings for its fourth quarter.
&bull; DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $241.59 million.
&bull; Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is expected to report earnings for its fourth quarter.
&bull; RVL Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVLP#NASDAQ">RVLP</a>) is expected to report quarterly loss at $0.16 per share on revenue of $12.60 million.
&bull; LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) is projected to report earnings for its fourth quarter.
&bull; PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) is estimated to report earnings for its fourth quarter.
&bull; Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) is likely to report earnings for its fourth quarter.
&bull; Abcam (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABCM#NASDAQ">ABCM</a>) is likely to report earnings for its Fiscal Year 2022.
&bull; Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) is estimated to report earnings for its fourth quarter.
&bull; Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $2.14 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is likely to report earnings for its fourth quarter.
&bull; Puyi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUYI#NASDAQ">PUYI</a>) is likely to report earnings for its first quarter.
&bull; Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is expected to report earnings for its fourth quarter.
&bull; Lantern Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) is expected to report earnings for its fourth quarter.
&bull; Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $23.92 million.
&bull; Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) is likely to report quarterly loss at $0.26 per share on revenue of $14.80 million.
&bull; Exagen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XGN#NASDAQ">XGN</a>) is estimated to report quarterly loss at $0.78 per share on revenue of $8.66 million.
&bull; Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is likely to report quarterly loss at $0.07 per share on revenue of $51.30 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ABCM

BAER

DFLI

DOYU

LITB

LTRN

MOVE

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PUYI

RVLP

SMTI

Earnings Scheduled For March 20, 2023

Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is set to give its latest quarterly earnings report on Monday, 2023-03-20. Here's what investors need to know before the announcement.
Analysts estimate that Flotek Industries will report an earnings per share (EPS) of $-0.07. 
Flotek Industries bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.19, which was followed by a 16.19% drop in the share price the next day.
Here's a look at Flotek Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2022</th>
<th>Q2 2022</th>
<th>Q1 2022</th>
<th>Q4 2021</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.06</td>
<td>-0.10</td>
<td>-0.06</td>
<td>-0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.25</td>
<td>-0.05</td>
<td>-0.15</td>
<td>-0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-16.19%</td>
<td>-3.23%</td>
<td>2.79%</td>
<td>-4.17%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1679061633_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Flotek Industries were trading at $0.9526 as of March 15. Over the last 52-week period, shares are down 37.5%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/FTK/earnings">To track all earnings releases for Flotek Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Flotek Industries

ProFrac Holding Corp, 10% Owner at Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>), reported a large insider buy on March 2, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001881487/000089924323006664//Archives/edgar/data/1881487/000089924323006664/0000899243-23-006664-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Corp purchased 1,500,000 shares of Flotek Industries. The total transaction amounted to $1,739,999. 
Flotek Industries shares are trading down 0.0% at $1.1 at the time of this writing on Thursday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001881487">Check Out The Full List Of Flotek Industries's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

1.74M Reasons To Be Bullish On Flotek Industries Stock

ProFrac Holding Corp, 10% Owner at Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>), reported a large insider buy on March 2, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000928054/000089924323006664//Archives/edgar/data/928054/000089924323006664/0000899243-23-006664-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Corp purchased 1,500,000 shares of Flotek Industries. The total transaction amounted to $1,739,999. 
Flotek Industries shares are trading down 0.0% at $1.1 at the time of this writing on Thursday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000928054">Check Out The Full List Of Flotek Industries's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Massive Insider Trade At Flotek Industries

Flotek Announces Leadership Transitions; Says Director Harsha V. Agadi Will Become Interim Chief Executive Officer, Succeeding John W. Gibson Jr.; Says Chief Operating Officer Ryan Ezell Has Been Promoted To President

Flotek Q4 2023 Earnings Preview

Flotek GAAP EPS of $0.07 misses by $0.01, revenue of $42.19M misses by $5.11M

Flotek (FTK) has issued an announcement. The Company has recently updated investors with a fresh presentation on its website, highlighting the late...

Flotek Unveils Operational Success in Latest Investor Update

Flotek Industries, Inc. 2023 Q4 - Results - Earnings Call Presentation

Flotek Industries, Inc. (FTK) Q4 2023 Earnings Call Transcript

Flotek Industries Inc (FTK) missed earnings projections on 3/12/2024 for Q4 2023.The consensus among analysts for Flotek Industries was for an earnings per share (EPS) of $0.09. The firm failed to meet those projections, reporting an EPS of $0.07, a negative surprise of $0.02 (-22%). Profits rose 105% year-over-year after

Flotek Industries Up 22.78% To $3.45 After Earnings Miss

These Energy stocks are trading higher:-Flotek Industries Inc (FTK) stock is trading at $3.42, an increase of $0.61, or 21.7%, on high volume.  Flotek Industries gets a Sentiment Score of Bearish from InvestorsObserver.  -PBF Energy Inc (PBF) stock is trading at $55.81, an increase of $5.37, or 10.8%, on average volume.  P

Energy Stocks Making Moves Wednesday: FTK, PBF, WKC, CVI, LBRT, PTEN, ACDC, GEL

FTK, PBF among major energy gainers; LBRT major loser

Commodity Roundup: Drone strikes on Russian refineries keep oil supported; gold down

These Energy stocks are trading higher:-Prairie Operating Co (PROP) stock is trading at $11.53, a gain of $1.47, or 14.68%, on high volume.  Prairie Operating CO gets a Sentiment Score of Very Bearish from InvestorsObserver. Prairie Operating CO next reports earnings on MarchÂ 19. -Flotek Industries Inc (FTK) stock is tradi

Energy Stocks Making Moves Friday: PROP, FTK, DK, OIS, HNRG, EURN, PFIE, ETRN

ACDC

CORN

CPER

DWSN

ETRN

EURN

GDXJ

HNRG

IMPP

LBRT

NUGT

PALL

PFIE

PHYS

PROP

PSLV

PTEN

SOYB

WEAT

Commodities

Press Releases

Flotek to Participate in Water Tower Research Fireside Chat

Flotek Projects Achieving Financial Milestone in Third Quarter and Announces 1-for-6 Reverse Stock Split

Flotek Bolsters Executive Leadership Team to Drive Innovation and Growth in Data Analytics Segment

Flotek Announces Timing of Release of Third Quarter 2023 Earnings Results and Conference Call

Flotek Announces Participation in the 36th Annual Roth Conference

Flotek Announces Timing of Fourth Quarter and Year-End 2023 Earnings Release and Conference Call

Flotek Strengthens Executive Leadership Team with the Addition of Amy Blakeway as Senior Vice President, General Counsel

Flotek Reports Fourth Quarter and Full-Year 2023 Results Highlighted by Growth in All Profitability Metrics Including a $31 Million Improvement in Annual Gross Profit

Flotek Announces Timing of First Quarter 2024 Earnings Release and Conference Call

Small Cap

EnerCom is Pleased to Announce that Registration is Now Open for the 29th Annual EnerCom Denver - The Energy Investment Conference